STERIS PE Ratio 2010-2023 | STE
Current and historical p/e ratio for STERIS (STE) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. STERIS PE ratio as of November 30, 2023 is 23.93.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
STERIS PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2023-11-30 | 200.94 | 177.82 | |
2023-09-30 | 218.85 | $1.13 | 193.67 |
2023-03-31 | 189.91 | $1.07 | 177.49 |
2022-12-31 | 182.91 | $-0.29 | 0.00 |
2022-09-30 | 164.24 | $-0.28 | 0.00 |
2022-06-30 | 203.14 | $4.29 | 47.35 |
2022-03-31 | 237.76 | $3.88 | 61.28 |
2023-06-30 | 223.88 | $3.12 | 71.75 |
2021-12-31 | 238.92 | $2.89 | 82.67 |
2021-09-30 | 200.14 | $2.80 | 71.48 |
2021-06-30 | 201.72 | $3.34 | 60.40 |
2021-03-31 | 185.86 | $4.61 | 40.32 |
2020-12-31 | 184.52 | $5.03 | 36.68 |
2020-09-30 | 171.16 | $4.93 | 34.72 |
2020-06-30 | 148.67 | $4.81 | 30.91 |
2020-03-31 | 135.29 | $4.77 | 28.36 |
2019-12-31 | 147.00 | $4.60 | 31.96 |
2019-09-30 | 139.01 | $3.93 | 35.37 |
2019-06-30 | 142.87 | $3.73 | 38.30 |
2019-03-31 | 122.56 | $3.56 | 34.43 |
2018-12-31 | 102.00 | $3.15 | 32.38 |
2018-09-30 | 108.89 | $3.70 | 29.43 |
2018-06-30 | 99.65 | $3.54 | 28.15 |
2018-03-31 | 88.34 | $3.40 | 25.98 |
2017-12-31 | 82.49 | $2.85 | 28.94 |
2017-09-30 | 83.07 | $1.68 | 49.45 |
2017-06-30 | 76.31 | $1.40 | 54.51 |
2017-03-31 | 64.81 | $1.28 | 50.63 |
2016-12-31 | 62.63 | $1.64 | 38.19 |
2016-09-30 | 67.65 | $1.96 | 34.51 |
2016-06-30 | 63.37 | $1.63 | 38.88 |
2016-03-31 | 65.26 | $1.47 | 44.39 |
2015-12-31 | 68.93 | $1.49 | 46.26 |
2015-09-30 | 59.44 | $1.86 | 31.96 |
2015-06-30 | 58.96 | $2.24 | 26.32 |
2015-03-31 | 64.29 | $2.25 | 28.57 |
2014-12-31 | 59.33 | $2.21 | 26.85 |
2014-09-30 | 49.37 | $2.06 | 23.97 |
2014-06-30 | 48.93 | $2.04 | 23.99 |
2014-03-31 | 43.69 | $2.17 | 20.13 |
2013-12-31 | 43.96 | $2.22 | 19.80 |
2013-09-30 | 39.12 | $2.56 | 15.28 |
2013-06-30 | 38.86 | $2.74 | 14.18 |
2013-03-31 | 37.55 | $2.72 | 13.80 |
2012-12-31 | 31.19 | $2.78 | 11.22 |
2012-09-30 | 31.67 | $2.54 | 12.47 |
2012-06-30 | 27.85 | $2.36 | 11.80 |
2012-03-31 | 27.91 | $2.32 | 12.03 |
2011-12-31 | 26.19 | $2.21 | 11.85 |
2011-09-30 | 25.55 | $1.99 | 12.84 |
2011-06-30 | 30.35 | $0.73 | 41.58 |
2011-03-31 | 29.84 | $0.75 | 39.78 |
2010-12-31 | 31.36 | $0.79 | 39.70 |
2010-06-30 | 26.48 | $0.97 | 27.30 |
2010-03-31 | 28.58 | $2.16 | 13.23 |
2009-12-31 | 23.67 | $2.13 | 11.11 |
2009-09-30 | 24.24 | $2.03 | 11.94 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $19.740B | $4.958B |
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $181.220B | 22.05 |
Intuitive Surgical (ISRG) | United States | $109.614B | 73.26 |
DexCom (DXCM) | United States | $42.099B | 80.71 |
Edwards Lifesciences (EW) | United States | $40.751B | 26.77 |
IDEXX Laboratories (IDXX) | United States | $39.278B | 48.26 |
IQVIA Holdings (IQV) | United States | $37.465B | 22.36 |
Alcon (ALC) | Switzerland | $35.104B | 28.82 |
Hologic (HOLX) | United States | $17.611B | 18.20 |
SONOVA HOLDING (SONVY) | Switzerland | $16.183B | 0.00 |
Waters (WAT) | United States | $15.428B | 21.80 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $11.508B | 14.53 |
Sysmex ADR (SSMXY) | Japan | $10.978B | 32.31 |
Teleflex (TFX) | United States | $10.091B | 15.72 |
Penumbra (PEN) | United States | $9.088B | 158.02 |
ShockWave Medical (SWAV) | United States | $6.457B | 27.26 |
Globus Medical (GMED) | United States | $6.253B | 19.56 |
Abcam (ABCM) | United Kingdom | $5.484B | 0.00 |
Masimo (MASI) | United States | $5.004B | 27.53 |
Inari Medical (NARI) | United States | $3.357B | 0.00 |
Elekta AB (EKTAY) | Sweden | $3.180B | 24.38 |
Glaukos (GKOS) | United States | $3.119B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $3.025B | 12.29 |
Integer Holdings (ITGR) | United States | $2.988B | 20.42 |
LivaNova (LIVN) | United Kingdom | $2.524B | 17.04 |
Pacific Biosciences Of California (PACB) | United States | $2.295B | 0.00 |
TransMedics (TMDX) | United States | $2.280B | 0.00 |
Nihon Kohden (NHNKY) | Japan | $2.179B | 18.16 |
Veracyte (VCYT) | United States | $1.902B | 0.00 |
PROCEPT BioRobotics (PRCT) | United States | $1.668B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.550B | 0.00 |
Tandem Diabetes Care (TNDM) | United States | $1.201B | 0.00 |
OPKO Health (OPK) | United States | $1.144B | 0.00 |
RxSight (RXST) | United States | $1.012B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.994B | 15.19 |
Paragon 28 (FNA) | United States | $0.858B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.744B | 0.00 |
SiBone (SIBN) | United States | $0.731B | 0.00 |
Nevro (NVRO) | United States | $0.600B | 0.00 |
Artivion (AORT) | United States | $0.580B | 70.60 |
IRadimed (IRMD) | United States | $0.541B | 33.28 |
Treace Medical Concepts (TMCI) | United States | $0.530B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.481B | 14.99 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.398B | 0.00 |
CVRx (CVRX) | United States | $0.379B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.344B | 0.00 |
Silk Road Medical (SILK) | United States | $0.323B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.297B | 10.90 |
AngioDynamics (ANGO) | United States | $0.274B | 0.00 |
Accuray (ARAY) | United States | $0.263B | 0.00 |
AxoGen (AXGN) | United States | $0.260B | 0.00 |
Semler Scientific (SMLR) | United States | $0.254B | 14.76 |
NeuroPace (NPCE) | United States | $0.229B | 0.00 |
908 Devices (MASS) | United States | $0.217B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.201B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.166B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.143B | 0.00 |
Inogen (INGN) | United States | $0.135B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.123B | 0.00 |
Sight Sciences (SGHT) | United States | $0.111B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.093B | 0.00 |
Hyperfine (HYPR) | United States | $0.084B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.076B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.075B | 0.00 |
InspireMD (NSPR) | Israel | $0.060B | 0.00 |
Delcath Systems (DCTH) | United States | $0.060B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.058B | 0.00 |
Eargo (EAR) | United States | $0.054B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.053B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.052B | 0.00 |
ReWalk Robotics (RWLK) | Israel | $0.044B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
Neuronetics (STIM) | United States | $0.039B | 0.00 |
Precision Optics (POCI) | United States | $0.037B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.035B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.034B | 0.00 |
DarioHealth (DRIO) | United States | $0.031B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.030B | 0.00 |
PAVmed (PAVM) | United States | $0.026B | 0.00 |
LENSAR (LNSR) | United States | $0.024B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
Spectral AI (MDAI) | United States | $0.018B | 0.00 |
Check-Cap (CHEK) | Israel | $0.017B | 0.00 |
Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
Envoy Medical (COCH) | United States | $0.015B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.013B | 0.00 |
NexGel (NXGL) | United States | $0.011B | 0.00 |
PetVivo Holdings (PETV) | United States | $0.010B | 0.00 |
Sientra (SIEN) | United States | $0.010B | 0.00 |
Venus Concept (VERO) | Canada | $0.009B | 0.00 |
Nemaura Medical (NMRD) | United States | $0.007B | 0.00 |
Tenon Medical (TNON) | United States | $0.005B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
Avinger (AVGR) | United States | $0.004B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
Dynatronics (DYNT) | United States | $0.002B | 0.00 |
Nuwellis (NUWE) | United States | $0.002B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |